{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T02:20:39Z","timestamp":1790130039816,"version":"4.0.1"},"reference-count":82,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2024,1,27]],"date-time":"2024-01-27T00:00:00Z","timestamp":1706313600000},"content-version":"vor","delay-in-days":1152,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2021,12,23]],"date-time":"2021-12-23T00:00:00Z","timestamp":1640217600000},"content-version":"vor","delay-in-days":387,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Kyowa Kirin International","award":["This manuscript was based on a series of meetings"],"award-info":[{"award-number":["This manuscript was based on a series of meetings"]}]}],"content-domain":{"domain":["asbmr.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,12,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Because of their rarity, diseases characterized by chronic hypophosphatemia can be underrecognized and suboptimally managed, resulting in poor clinical outcomes. Moreover, serum phosphate may not be measured routinely in primary care practice. Authors participated in several working sessions to advance the understanding of phosphate homeostasis and the causes, consequences, and clinical implications of chronic hypophosphatemia. Phosphate levels are regulated from birth to adulthood. Dysregulation of phosphate homeostasis can result in hypophosphatemia, which becomes chronic if phosphate levels cannot be normalized. Chronic hypophosphatemia may be underrecognized as serum phosphate measurement is not always part of routine analysis in the primary care setting and results might be misinterpreted, for instance, due to age-specific differences not being accounted for and circadian variations. Clinical consequences of chronic hypophosphatemia involve disordered endocrine regulation, affect multiple organ systems, and vary depending on patient age and the underlying disorder. Signs and symptoms of chronic hypophosphatemic diseases that manifest during childhood or adolescence persist into adulthood if the disease is inadequately managed, resulting in an accumulation of clinical deficits and a progressive, debilitating impact on quality of life. Early identification and diagnosis of patients with chronic hypophosphatemia is crucial, and clinical management should be started as soon as possible to maximize the likelihood of improving health outcomes. Furthermore, in the absence of a universally accepted description for \u201cchronic hypophosphatemia,\u201d a definition is proposed here that aims to raise awareness of these diseases, facilitate diagnosis, and guide optimal phosphate management strategies by improving monitoring and assessment of patient response to treatment. \u00a9 2021 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR).<\/jats:p>","DOI":"10.1002\/jbmr.4486","type":"journal-article","created":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T05:49:18Z","timestamp":1638769758000},"page":"12-20","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["An Expert Perspective on Phosphate Dysregulation With a Focus on Chronic Hypophosphatemia"],"prefix":"10.1093","volume":"37","author":[{"given":"Fahad","family":"Aljuraibah","sequence":"first","affiliation":[{"name":"College of Medicine King Saud bin Abdulaziz University for Health Sciences Riyadh Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine","family":"Bacchetta","sequence":"additional","affiliation":[{"name":"H\u00f4pital Femme M\u00e8re Enfant, INSERM1033 Research Unit Bron France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luisa","family":"Brandi","sequence":"additional","affiliation":[{"name":"University of Florence Florence Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5936-3146","authenticated-orcid":false,"given":"Pablo","family":"Florenzano","sequence":"additional","affiliation":[{"name":"Pontificia Universidad Cat\u00f3lica de Chile Santiago Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7985-0048","authenticated-orcid":false,"given":"Muhammad K","family":"Javaid","sequence":"additional","affiliation":[{"name":"University of Oxford Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4547-001X","authenticated-orcid":false,"given":"Outimaija","family":"M\u00e4kitie","sequence":"additional","affiliation":[{"name":"Children's Hospital, University of Helsinki and Helsinki University Hospital Helsinki Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adalbert","family":"Raimann","sequence":"additional","affiliation":[{"name":"Medical University of Vienna Vienna Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Rodriguez","sequence":"additional","affiliation":[{"name":"Hospital Universitario Reina Sofia, IMIBIC C\u00f3rdoba Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heide","family":"Siggelkow","sequence":"additional","affiliation":[{"name":"University Medical Center G\u00f6ttingen Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dov","family":"Tiosano","sequence":"additional","affiliation":[{"name":"Rambam Medical Center Haifa Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Vervloet","sequence":"additional","affiliation":[{"name":"Amsterdam University Medical Center Amsterdam The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9874-8898","authenticated-orcid":false,"given":"Carsten A","family":"Wagner","sequence":"additional","affiliation":[{"name":"Swiss National Center of Competence in Research NCCR Kidney.CH Zurich"},{"name":"University of Zurich Zurich"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,12,6]]},"reference":[{"issue":"3","key":"2024012714043914900_jbmr4486-bib-0001","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/cphy.c170024","article-title":"Mechanisms and regulation of intestinal phosphate absorption","volume":"8","author":"Hernando","year":"2018","journal-title":"Compr Physiol."},{"issue":"6","key":"2024012714043914900_jbmr4486-bib-0002","doi-asserted-by":"crossref","first-page":"860","DOI":"10.3945\/an.115.008516","article-title":"Phosphorus","volume":"6","author":"Calvo","year":"2015","journal-title":"Adv Nutr."},{"issue":"2","key":"2024012714043914900_jbmr4486-bib-0003","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S2213-8587(19)30426-7","article-title":"Approach to patients with hypophosphataemia","volume":"8","author":"Florenzano","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"10","key":"2024012714043914900_jbmr4486-bib-0004","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1007\/s00467-019-04290-y","article-title":"Mineralized tissues in hypophosphatemic rickets","volume":"35","author":"Robinson","year":"2020","journal-title":"Pediatr Nephrol."},{"key":"2024012714043914900_jbmr4486-bib-0005","doi-asserted-by":"crossref","first-page":"E1492","DOI":"10.1210\/jc.2012-1336","article-title":"Abnormalities in muscle density and muscle function in hypophosphatemic rickets","volume":"97","author":"Veilleux","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2024012714043914900_jbmr4486-bib-0006","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11914-016-0309-0","article-title":"Hypophosphatasia","volume":"14","author":"Linglart","year":"2016","journal-title":"Curr Osteoporos Rep."},{"issue":"1","key":"2024012714043914900_jbmr4486-bib-0007","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00223-020-00664-9","article-title":"The causes of hypo- and hyperphosphatemia in humans","volume":"108","author":"Koumakis","year":"2021","journal-title":"Calcif Tissue Int."},{"issue":"1","key":"2024012714043914900_jbmr4486-bib-0008","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13023-019-1014-8","article-title":"FGF23 and its role in X-linked hypophosphatemia-related morbidity","volume":"14","author":"Beck-Nielsen","year":"2019","journal-title":"Orphanet J Rare Dis."},{"issue":"4","key":"2024012714043914900_jbmr4486-bib-0009","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.afos.2018.12.001","article-title":"Tumor-induced osteomalacia","volume":"4","author":"Yin","year":"2018","journal-title":"Osteopor Sarcop."},{"key":"2024012714043914900_jbmr4486-bib-0010","article-title":"Hypophosphataemia, fibroblast growth factor 23 and third-generation intravenous iron compounds: a narrative review","volume":"10:2020-11-3","author":"Kassianides","year":"2021","journal-title":"Drugs Context."},{"issue":"5","key":"2024012714043914900_jbmr4486-bib-0011","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/ajh.26100","article-title":"Parenteral iron therapy and phosphorus homeostasis: a review","volume":"96","author":"Kalantar-Zadeh","year":"2021","journal-title":"Am J Hematol."},{"key":"2024012714043914900_jbmr4486-bib-0012","doi-asserted-by":"crossref","first-page":"100862","DOI":"10.1016\/j.mam.2020.100862","article-title":"Intravenous iron supplementation therapy","volume":"75","author":"Schaefer","year":"2020","journal-title":"Mol Aspects Med."},{"key":"2024012714043914900_jbmr4486-bib-0013","author":"Linglart"},{"issue":"2","key":"2024012714043914900_jbmr4486-bib-0014","doi-asserted-by":"crossref","first-page":"176","DOI":"10.17294\/2330-0698.1727","article-title":"Giving credence to the experience of X-linked hypophosphatemia in adulthood: an interprofessional mixed-methods study","volume":"7","author":"Hughes","year":"2020","journal-title":"J Patient Cent Res Rev Spring."},{"key":"2024012714043914900_jbmr4486-bib-0015","author":"Mayo Clinic","year":"2021"},{"issue":"5","key":"2024012714043914900_jbmr4486-bib-0016","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00431-007-0662-1","article-title":"What's new in hypophosphataemic rickets?","volume":"167","author":"Pettifor","year":"2008","journal-title":"Eur J Pediatr."},{"issue":"10","key":"2024012714043914900_jbmr4486-bib-0017","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1210\/clinem\/dgab495","article-title":"Phosphate concentrations and modifying factors in healthy children from 12 to 24 months of age","volume":"106","author":"Koljonen","year":"2021","journal-title":"J Clin Endocrinol Metab."},{"issue":"8","key":"2024012714043914900_jbmr4486-bib-0018","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1056\/NEJMc0800696","article-title":"Age, renal tubular phosphate reabsorption, and serum phosphate levels in adults","volume":"359","author":"Cirillo","year":"2008","journal-title":"N Engl J Med."},{"issue":"5","key":"2024012714043914900_jbmr4486-bib-0019","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1053\/j.ajkd.2011.06.011","article-title":"Relation of sex and estrogen therapy to serum fibroblast growth factor 23, serum phosphorus, and urine phosphorus: the heart and soul study","volume":"58","author":"Ix","year":"2011","journal-title":"Am J Kidney Dis."},{"issue":"1","key":"2024012714043914900_jbmr4486-bib-0020","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1053\/j.ajkd.2015.06.027","article-title":"Sex, age, and the association of serum phosphorus with all-cause mortality in adults with normal kidney function","volume":"67","author":"Yoo","year":"2016","journal-title":"Am J Kidney Dis."},{"issue":"8","key":"2024012714043914900_jbmr4486-bib-0021","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/s41581-019-0159-y","article-title":"Mechanisms of phosphate transport","volume":"15","author":"Levi","year":"2019","journal-title":"Nat Rev Nephrol."},{"issue":"15","key":"2024012714043914900_jbmr4486-bib-0022","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1002\/1873-3468.13494","article-title":"Regulation of fibroblast growth factor 23 (FGF23) in health and disease","volume":"593","author":"Bar","year":"2019","journal-title":"FEBS Lett."},{"issue":"8","key":"2024012714043914900_jbmr4486-bib-0023","doi-asserted-by":"crossref","first-page":"e10190","DOI":"10.1002\/jbm4.10190","article-title":"FGF23, hypophosphatemia, and emerging treatments","volume":"3","author":"Imel","year":"2019","journal-title":"JBMR Plus."},{"issue":"3","key":"2024012714043914900_jbmr4486-bib-0024","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis","volume":"19","author":"Shimada","year":"2004","journal-title":"J Bone Miner Res."},{"key":"2024012714043914900_jbmr4486-bib-0025","volume-title":"Primary disorders of phosphate metabolism","author":"Carpenter","year":"2000"},{"issue":"2","key":"2024012714043914900_jbmr4486-bib-0026","doi-asserted-by":"crossref","first-page":"120","DOI":"10.4248\/BR201302002","article-title":"FGF23 and phosphate wasting disorders","volume":"1","author":"Huang","year":"2013","journal-title":"Bone Res."},{"issue":"1","key":"2024012714043914900_jbmr4486-bib-0027","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.nurpra.2011.05.007","article-title":"Consequences and management strategies","volume":"8","author":"Nguyen","year":"2012","journal-title":"J Nurse Pract."},{"issue":"Pt 6","key":"2024012714043914900_jbmr4486-bib-0028","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1177\/0004563214521399","article-title":"Phosphate homeostasis and disorders","volume":"51","author":"Manghat","year":"2014","journal-title":"Ann Clin Biochem."},{"issue":"5","key":"2024012714043914900_jbmr4486-bib-0029","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.berh.2011.10.020","article-title":"Hyperphosphatemic familial tumoral calcinosis (FGF23, GALNT3 and \u03b1Klotho)","volume":"25","author":"Farrow","year":"2011","journal-title":"Best Pract Res Clin Rheumatol."},{"issue":"1","key":"2024012714043914900_jbmr4486-bib-0030","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nrneph.2016.164","article-title":"The role of phosphate in kidney disease","volume":"13","author":"Vervloet","year":"2017","journal-title":"Nat Rev Nephrol."},{"issue":"5","key":"2024012714043914900_jbmr4486-bib-0031","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.kint.2017.11.036","article-title":"Prevention and treatment of hyperphosphatemia in chronic kidney disease","volume":"93","author":"Vervloet","year":"2018","journal-title":"Kidney Int."},{"issue":"1","key":"2024012714043914900_jbmr4486-bib-0032","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1042\/CS20190895","article-title":"Inflammation: a putative link between phosphate metabolism and cardiovascular disease","volume":"135","author":"Voelkl","year":"2021","journal-title":"Clin Sci."},{"issue":"7","key":"2024012714043914900_jbmr4486-bib-0033","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41581-019-0152-5","article-title":"Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia","volume":"15","author":"Haffner","year":"2019","journal-title":"Nat Rev Nephrol."},{"issue":"12","key":"2024012714043914900_jbmr4486-bib-0034","doi-asserted-by":"crossref","first-page":"3820","DOI":"10.1172\/JCI36479","article-title":"Endocrine functions of bone in mineral metabolism regulation","volume":"118","author":"Quarles","year":"2008","journal-title":"J Clin Invest."},{"key":"2024012714043914900_jbmr4486-bib-0035","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2147\/TCRM.S243462","article-title":"Hypophosphatemia associated with intravenous iron therapies for iron deficiency anemia: a systematic literature review","volume":"16","author":"Glaspy","year":"2020","journal-title":"Ther Clin Risk Manag."},{"issue":"8","key":"2024012714043914900_jbmr4486-bib-0036","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1093\/rheumatology\/kez627","article-title":"Novel use of burosumab in refractory iron-induced FGF23-mediated hypophosphataemic osteomalacia","volume":"59","author":"Amarnani","year":"2020","journal-title":"Rheumatology."},{"key":"2024012714043914900_jbmr4486-bib-0037","doi-asserted-by":"crossref","first-page":"153865","DOI":"10.1016\/j.metabol.2019.01.006","article-title":"Physiology of FGF23 and overview of genetic diseases associated with renal phosphate wasting","volume":"103S","author":"Bacchetta","year":"2020","journal-title":"Metabolism."},{"issue":"2","key":"2024012714043914900_jbmr4486-bib-0038","first-page":"59","article-title":"Hypophosphataemia in burns","volume":"22","author":"Castana","year":"2009","journal-title":"Ann Burns Fire Disasters."},{"issue":"2","key":"2024012714043914900_jbmr4486-bib-0039","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/joor.13114","article-title":"Oral health-related quality of life in X-linked hypophosphatemia and osteogenesis imperfecta","volume":"48","author":"Gjorup","year":"2021","journal-title":"J Oral Rehabil."},{"issue":"7","key":"2024012714043914900_jbmr4486-bib-0040","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1007\/s11136-020-02465-x","article-title":"Exploring the burden of X-linked hypophosphatemia: a European multi-country qualitative study","volume":"29","author":"Lo","year":"2020","journal-title":"Qual Life Res."},{"issue":"7","key":"2024012714043914900_jbmr4486-bib-0041","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1210\/js.2018-00365","article-title":"The lifelong impact of X-linked hypophosphatemia: results from a burden of disease survey","volume":"3","author":"Skrinar","year":"2019","journal-title":"J Endocr Soc."},{"issue":"4","key":"2024012714043914900_jbmr4486-bib-0042","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s11914-017-0383-y","article-title":"Nutritional rickets and osteomalacia in the twenty-first century: revised concepts, public health, and prevention strategies","volume":"15","author":"Uday","year":"2017","journal-title":"Curr Osteoporos Rep."},{"issue":"4","key":"2024012714043914900_jbmr4486-bib-0043","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s00774-009-0079-1","article-title":"Hypophosphatemia: the common denominator of all rickets","volume":"27","author":"Tiosano","year":"2009","journal-title":"J Bone Miner Metab."},{"issue":"1","key":"2024012714043914900_jbmr4486-bib-0044","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00424-018-2184-2","article-title":"Hereditary hypophosphatemic rickets with hypercalciuria: pathophysiology, clinical presentation, diagnosis and therapy","volume":"471","author":"Bergwitz","year":"2019","journal-title":"Pflugers Arch."},{"issue":"suppl 1","key":"2024012714043914900_jbmr4486-bib-0045","first-page":"119","article-title":"Spontaneous growth and effect of early therapy with calcitriol and phosphate in X-linked hypophosphatemic rickets","volume":"15","author":"Cagnoli","year":"2017","journal-title":"Pediatr Endocrinol Rev."},{"key":"2024012714043914900_jbmr4486-bib-0046","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.gaitpost.2020.07.007","article-title":"Disease-specific gait deviations in pediatric patients with X-linked hypophosphatemia","volume":"81","author":"Mindler","year":"2020","journal-title":"Gait Posture."},{"issue":"5\u20136","key":"2024012714043914900_jbmr4486-bib-0047","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s10354-019-00732-2","article-title":"Multidisciplinary patient care in X-linked hypophosphatemic rickets: one challenge, many perspectives","volume":"170","author":"Raimann","year":"2020","journal-title":"Wien Med Wochenschr."},{"key":"2024012714043914900_jbmr4486-bib-0048","volume-title":"GeneReviews((R))","author":"Ruppe","year":"2017"},{"issue":"5\u20136","key":"2024012714043914900_jbmr4486-bib-0049","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.rehab.2016.07.004","article-title":"An update on the pathophysiology of osteoarthritis","volume":"59","author":"Mobasheri","year":"2016","journal-title":"Ann Phys Rehabil Med."},{"issue":"8","key":"2024012714043914900_jbmr4486-bib-0050","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1002\/jbmr.3475","article-title":"A randomized, double-blind, placebo-controlled, phase 3 trial evaluating the efficacy of burosumab, an anti-FGF23 antibody, in adults with X-linked hypophosphatemia: week 24 primary analysis","volume":"33","author":"Insogna","year":"2018","journal-title":"J Bone Miner Res."},{"issue":"2","key":"2024012714043914900_jbmr4486-bib-0051","doi-asserted-by":"crossref","first-page":"141","DOI":"10.5001\/omj.2010.38","article-title":"Looser's zone","volume":"25","author":"Ahmad","year":"2010","journal-title":"Oman Med J."},{"issue":"7","key":"2024012714043914900_jbmr4486-bib-0052","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/jbmr.340","article-title":"A clinician's guide to X-linked hypophosphatemia","volume":"26","author":"Carpenter","year":"2011","journal-title":"J Bone Miner Res."},{"issue":"4","key":"2024012714043914900_jbmr4486-bib-0053","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1359\/jbmr.091021","article-title":"Acute phosphate restriction leads to impaired fracture healing and resistance to BMP-2","volume":"25","author":"Wigner","year":"2010","journal-title":"J Bone Miner Res."},{"issue":"7","key":"2024012714043914900_jbmr4486-bib-0054","doi-asserted-by":"crossref","first-page":"dgaa242","DOI":"10.1210\/clinem\/dgaa242","article-title":"Enthesopathy, osteoarthritis, and mobility in X-linked hypophosphatemia1","volume":"105","author":"Imel","year":"2020","journal-title":"J Clin Endocrinol Metab."},{"issue":"8","key":"2024012714043914900_jbmr4486-bib-0055","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/jbmr.3544","article-title":"Burosumab: at long last, an effective treatment for FGF23-associated hypophosphatemia","volume":"33","author":"Collins","year":"2018","journal-title":"J Bone Miner Res."},{"issue":"7","key":"2024012714043914900_jbmr4486-bib-0056","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.2215\/CJN.15201218","article-title":"Burosumab therapy for X-linked hypophosphatemia and therapeutic implications for CKD","volume":"14","author":"Perwad","year":"2019","journal-title":"Clin J Am Soc Nephrol."},{"issue":"6","key":"2024012714043914900_jbmr4486-bib-0057","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1210\/en.2018-00184","article-title":"FGF23 regulates Wnt\/beta-catenin signaling-mediated osteoarthritis in mice overexpressing high-molecular-weight FGF2","volume":"159","author":"Meo Burt","year":"2018","journal-title":"Endocrinology."},{"issue":"10","key":"2024012714043914900_jbmr4486-bib-0058","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1096\/fj.201600473R","article-title":"Hypophosphatemia promotes lower rates of muscle ATP synthesis","volume":"30","author":"Pesta","year":"2016","journal-title":"FASEB J."},{"issue":"3","key":"2024012714043914900_jbmr4486-bib-0059","doi-asserted-by":"crossref","first-page":"E509","DOI":"10.1210\/jc.2012-3592","article-title":"Improving the vitamin D status of vitamin D deficient adults is associated with improved mitochondrial oxidative function in skeletal muscle","volume":"98","author":"Sinha","year":"2013","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2024012714043914900_jbmr4486-bib-0060","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/sca.21141","article-title":"X-linked hypophosphatemic rickets: enamel abnormalities and oral clinical findings","volume":"36","author":"Cremonesi","year":"2014","journal-title":"Scanning."},{"issue":"2","key":"2024012714043914900_jbmr4486-bib-0061","first-page":"61","article-title":"Prevalence and pathogenesis of dental and periodontal lesions in children with X-linked hypophosphatemic rickets","volume":"7","author":"Baroncelli","year":"2006","journal-title":"Eur J Paediatr Dent."},{"issue":"5","key":"2024012714043914900_jbmr4486-bib-0062","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s10545-018-0147-6","article-title":"Outcome of adult patients with X-linked hypophosphatemia caused by PHEX gene mutations","volume":"41","author":"Chesher","year":"2018","journal-title":"J Inherit Metab Dis."},{"issue":"8","key":"2024012714043914900_jbmr4486-bib-0063","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jval.2018.01.013","article-title":"Qualitative research to explore the patient experience of X-linked hypophosphatemia and evaluate the suitability of the BPI-SF and WOMAC(R) as clinical trial end points","volume":"21","author":"Theodore-Oklota","year":"2018","journal-title":"Value Health."},{"issue":"suppl 5","key":"2024012714043914900_jbmr4486-bib-0064","doi-asserted-by":"crossref","first-page":"S515","DOI":"10.1542\/peds.2017-2522","article-title":"Craniosynostosis as the presenting feature of X-linked hypophosphatemic rickets","volume":"141","author":"Vakharia","year":"2018","journal-title":"Pediatrics."},{"issue":"3","key":"2024012714043914900_jbmr4486-bib-0065","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/jbmr.3614","article-title":"High incidence of cranial synostosis and Chiari I malformation in children with X-linked hypophosphatemic rickets (XLHR)","volume":"34","author":"Rothenbuhler","year":"2019","journal-title":"J Bone Miner Res."},{"issue":"3","key":"2024012714043914900_jbmr4486-bib-0066","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1530\/EJE-15-0661","article-title":"Impaired quality of life in adults with X-linked hypophosphatemia and skeletal symptoms","volume":"174","author":"Che","year":"2016","journal-title":"Eur J Endocrinol."},{"issue":"1","key":"2024012714043914900_jbmr4486-bib-0067","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1530\/EC-13-0103","article-title":"Therapeutic management of hypophosphatemic rickets from infancy to adulthood","volume":"3","author":"Linglart","year":"2014","journal-title":"Endocr Connect."},{"issue":"8","key":"2024012714043914900_jbmr4486-bib-0068","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1210\/jc.2003-030036","article-title":"Early treatment improves growth and biochemical and radiographic outcome in X-linked hypophosphatemic rickets","volume":"88","author":"Makitie","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"key":"2024012714043914900_jbmr4486-bib-0069","author":"Zhukouskaya","year":"2019"},{"issue":"2","key":"2024012714043914900_jbmr4486-bib-0070","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1530\/EJE-15-0515","article-title":"Hereditary hypophosphatemia in Norway: a retrospective population-based study of genotypes, phenotypes, and treatment complications","volume":"174","author":"Rafaelsen","year":"2016","journal-title":"Eur J Endocrinol."},{"issue":"7","key":"2024012714043914900_jbmr4486-bib-0071","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/qjmed\/hcq039","article-title":"Medication-induced hypophosphatemia: a review","volume":"103","author":"Liamis","year":"2010","journal-title":"QJM."},{"key":"2024012714043914900_jbmr4486-bib-0072","first-page":"378","article-title":"How to identify and treat hypophosphataemia","volume":"15","author":"Lippett","year":"2008","journal-title":"Hosp Pharm."},{"issue":"1","key":"2024012714043914900_jbmr4486-bib-0073","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1053\/j.ajkd.2011.08.035","article-title":"Evaluation of hypophosphatemia: lessons from patients with genetic disorders","volume":"59","author":"Bacchetta","year":"2012","journal-title":"Am J Kidney Dis."},{"key":"2024012714043914900_jbmr4486-bib-0074","author":"Takeda"},{"issue":"3","key":"2024012714043914900_jbmr4486-bib-0075","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1530\/ERC-11-0006","article-title":"Tumor-induced osteomalacia","volume":"18","author":"Chong","year":"2011","journal-title":"Endocr Relat Cancer."},{"key":"2024012714043914900_jbmr4486-bib-0076","author":"Mayo Clinic","year":"2021"},{"key":"2024012714043914900_jbmr4486-bib-0077","author":"Holland","year":"2014"},{"key":"2024012714043914900_jbmr4486-bib-0078","author":"McConnell","year":"2000"},{"issue":"4","key":"2024012714043914900_jbmr4486-bib-0079","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1053\/j.ajkd.2014.04.028","article-title":"Serum phosphorus and mortality in the third National Health and Nutrition Examination Survey (NHANES III): effect modification by fasting","volume":"64","author":"Chang","year":"2014","journal-title":"Am J Kidney Dis."},{"issue":"3","key":"2024012714043914900_jbmr4486-bib-0080","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00223-019-00568-3","article-title":"Continued beneficial effects of burosumab in adults with X-linked hypophosphatemia: results from a 24-week treatment continuation period after a 24-week double-blind placebo-controlled period","volume":"105","author":"Portale","year":"2019","journal-title":"Calcif Tissue Int."},{"key":"2024012714043914900_jbmr4486-bib-0081","author":"Brandi","year":"2020"},{"issue":"12","key":"2024012714043914900_jbmr4486-bib-0082","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1002\/jbmr.3843","article-title":"Burosumab improved histomorphometric measures of osteomalacia in adults with X-linked hypophosphatemia: a phase 3, single-arm, international trial","volume":"34","author":"Insogna","year":"2019","journal-title":"J Bone Miner Res."}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jbmr.4486","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jbmr.4486","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/37\/1\/12\/55459550\/jbmr4486.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/37\/1\/12\/55459550\/jbmr4486.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T11:08:20Z","timestamp":1710328100000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/37\/1\/12-20\/7512187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,1]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12,6]]},"published-print":{"date-parts":[[2020,12,1]]}},"URL":"https:\/\/doi.org\/10.1002\/jbmr.4486","relation":{"has-review":[{"id-type":"doi","id":"10.1002\/JBMR.4486\/v3\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4486\/v1\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4486\/v1\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4486\/v2\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4486\/v2\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4486\/v1\/decision1","asserted-by":"object"}]},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,12,1]]},"published":{"date-parts":[[2020,12,1]]},"assertion":[{"value":"2021-07-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-27","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-23","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}